title: Should South Africa be preparing for HIV-1 vaccine efficacy trials?
authors.forename: L
authors.initials: L
authors.lastname: Morris
authors.forename: E
authors.initials: E
authors.lastname: van der Ryst
authors.forename: C
authors.initials: C
authors.lastname: Gray
authors.forename: C
authors.initials: C
authors.lastname: Williamson
mesh_terms: D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000517:prevention & control; D000818:Animals; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D013019:South Africa / Q000453:epidemiology
chemical_list: D016915:AIDS Vaccines